vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $282.3M, roughly 1.7× Getty Images Holdings, Inc.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -32.2%, a 22.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 14.1%). Getty Images Holdings, Inc. produced more free cash flow last quarter ($7.7M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 12.7%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.

CLOV vs GETY — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.7× larger
CLOV
$487.7M
$282.3M
GETY
Growing faster (revenue YoY)
CLOV
CLOV
+30.6% gap
CLOV
44.7%
14.1%
GETY
Higher net margin
CLOV
CLOV
22.1% more per $
CLOV
-10.1%
-32.2%
GETY
More free cash flow
GETY
GETY
$76.7M more FCF
GETY
$7.7M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
12.7%
GETY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
GETY
GETY
Revenue
$487.7M
$282.3M
Net Profit
$-49.3M
$-90.9M
Gross Margin
74.8%
Operating Margin
-10.1%
-8.5%
Net Margin
-10.1%
-32.2%
Revenue YoY
44.7%
14.1%
Net Profit YoY
-123.2%
-467.6%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GETY
GETY
Q4 25
$487.7M
$282.3M
Q3 25
$496.6M
$240.0M
Q2 25
$477.6M
$234.9M
Q1 25
$462.3M
$224.1M
Q4 24
$337.0M
$247.3M
Q3 24
$331.0M
$240.5M
Q2 24
$356.3M
$229.1M
Q1 24
$346.9M
$222.3M
Net Profit
CLOV
CLOV
GETY
GETY
Q4 25
$-49.3M
$-90.9M
Q3 25
$-24.4M
$21.6M
Q2 25
$-10.6M
$-34.4M
Q1 25
$-1.3M
$-102.6M
Q4 24
$-22.1M
$24.7M
Q3 24
$-9.2M
$-2.5M
Q2 24
$7.4M
$3.7M
Q1 24
$-19.2M
$13.6M
Gross Margin
CLOV
CLOV
GETY
GETY
Q4 25
74.8%
Q3 25
73.2%
Q2 25
72.1%
Q1 25
73.1%
Q4 24
73.5%
Q3 24
24.5%
73.4%
Q2 24
30.3%
72.5%
Q1 24
23.6%
72.9%
Operating Margin
CLOV
CLOV
GETY
GETY
Q4 25
-10.1%
-8.5%
Q3 25
-4.9%
18.8%
Q2 25
-2.2%
15.1%
Q1 25
-0.3%
12.2%
Q4 24
-6.4%
14.5%
Q3 24
-2.7%
23.9%
Q2 24
2.0%
20.3%
Q1 24
-6.5%
18.5%
Net Margin
CLOV
CLOV
GETY
GETY
Q4 25
-10.1%
-32.2%
Q3 25
-4.9%
9.0%
Q2 25
-2.2%
-14.6%
Q1 25
-0.3%
-45.8%
Q4 24
-6.6%
10.0%
Q3 24
-2.8%
-1.1%
Q2 24
2.1%
1.6%
Q1 24
-5.5%
6.1%
EPS (diluted)
CLOV
CLOV
GETY
GETY
Q4 25
$-0.22
Q3 25
$0.05
Q2 25
$-0.08
Q1 25
$-0.25
Q4 24
$0.07
Q3 24
$-0.01
Q2 24
$0.01
Q1 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GETY
GETY
Cash + ST InvestmentsLiquidity on hand
$78.3M
$90.2M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$308.7M
$552.5M
Total Assets
$541.0M
$3.2B
Debt / EquityLower = less leverage
2.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GETY
GETY
Q4 25
$78.3M
$90.2M
Q3 25
$109.5M
Q2 25
$110.3M
Q1 25
$114.6M
Q4 24
$194.5M
$121.2M
Q3 24
$288.0M
$109.9M
Q2 24
$254.8M
$121.7M
Q1 24
$208.3M
$134.2M
Total Debt
CLOV
CLOV
GETY
GETY
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.4B
Stockholders' Equity
CLOV
CLOV
GETY
GETY
Q4 25
$308.7M
$552.5M
Q3 25
$340.9M
$634.6M
Q2 25
$344.2M
$611.2M
Q1 25
$336.1M
$593.0M
Q4 24
$341.1M
$670.2M
Q3 24
$342.2M
$683.4M
Q2 24
$324.9M
$654.0M
Q1 24
$292.5M
$640.8M
Total Assets
CLOV
CLOV
GETY
GETY
Q4 25
$541.0M
$3.2B
Q3 25
$559.7M
$2.6B
Q2 25
$575.0M
$2.6B
Q1 25
$583.7M
$2.6B
Q4 24
$580.7M
$2.6B
Q3 24
$653.0M
$2.6B
Q2 24
$674.2M
$2.6B
Q1 24
$671.8M
$2.6B
Debt / Equity
CLOV
CLOV
GETY
GETY
Q4 25
2.30×
Q3 25
2.11×
Q2 25
2.19×
Q1 25
2.21×
Q4 24
1.96×
Q3 24
1.97×
Q2 24
2.06×
Q1 24
2.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
GETY
GETY
Operating Cash FlowLast quarter
$-66.9M
$20.6M
Free Cash FlowOCF − Capex
$-69.0M
$7.7M
FCF MarginFCF / Revenue
-14.1%
2.7%
Capex IntensityCapex / Revenue
0.4%
4.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
GETY
GETY
Q4 25
$-66.9M
$20.6M
Q3 25
$12.1M
$22.6M
Q2 25
$5.4M
$6.5M
Q1 25
$-16.3M
$15.4M
Q4 24
$34.8M
$39.7M
Q3 24
$50.0M
$10.7M
Q2 24
$44.8M
$46.4M
Q1 24
$25.9M
$21.5M
Free Cash Flow
CLOV
CLOV
GETY
GETY
Q4 25
$-69.0M
$7.7M
Q3 25
$11.4M
$7.9M
Q2 25
$4.8M
$-9.6M
Q1 25
$-16.5M
$-322.0K
Q4 24
$33.3M
$24.6M
Q3 24
$49.6M
$-1.8M
Q2 24
$44.4M
$31.1M
Q1 24
$25.5M
$7.1M
FCF Margin
CLOV
CLOV
GETY
GETY
Q4 25
-14.1%
2.7%
Q3 25
2.3%
3.3%
Q2 25
1.0%
-4.1%
Q1 25
-3.6%
-0.1%
Q4 24
9.9%
9.9%
Q3 24
15.0%
-0.8%
Q2 24
12.5%
13.6%
Q1 24
7.3%
3.2%
Capex Intensity
CLOV
CLOV
GETY
GETY
Q4 25
0.4%
4.6%
Q3 25
0.1%
6.1%
Q2 25
0.1%
6.9%
Q1 25
0.0%
7.0%
Q4 24
0.5%
6.1%
Q3 24
0.1%
5.2%
Q2 24
0.1%
6.7%
Q1 24
0.1%
6.5%
Cash Conversion
CLOV
CLOV
GETY
GETY
Q4 25
Q3 25
1.05×
Q2 25
Q1 25
Q4 24
1.61×
Q3 24
Q2 24
6.04×
12.59×
Q1 24
1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

GETY
GETY

Creative$149.0M53%
Editorial$109.4M39%
Other$23.9M8%

Related Comparisons